Cytokeratin 19 Fragment/Carcinoembryonic Antigen Ratio in Pleural Effusion Is a Useful Marker for Detecting Malignant Pleural Mesothelioma

被引:2
|
作者
Suzuki, Hidekazu [1 ]
Hirashima, Tomonori [1 ]
Kobayashi, Masashi [1 ]
Sasada, Shinji [1 ]
Okamoto, Norio [1 ]
Uehara, Nobuko [1 ]
Tamiya, Motohiro [1 ]
Matsuura, Yuka [1 ]
Morishita, Naoko [1 ]
Kawase, Ichiro [1 ]
机构
[1] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Habikino, Osaka 5838588, Japan
关键词
Tumour marker; receiver operating characteristic curve; diagnosis; CYFRA; 21-1; CARCINOEMBRYONIC ANTIGEN; DIAGNOSTIC-VALUE; DIFFERENTIAL-DIAGNOSIS; TUMOR-MARKERS; FLUID; CEA; SERUM; FRAGMENTS; CA-19-9;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The clinical utility of tumour markers in pleural effusion is still controversial with regard to the efficient detection of malignant pleural mesothelioma (MPM). Patients and Methods: The levels of carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21-1) were retrospectively studied in pleural effusion of unknown origin in patients who had undergone medical thoracoscopy under local anaesthesia. Results: The study included 134 patients (103 men and 31 women); among them, 33 had MPM. The level of pleural effusion CYFRA 21-1 and the CYFRA 21-1/CEA ratio were significantly different between MPM and other diseases (p<0.01). The sensitivity and specificity of the pleural elision CYFRA 21-1/CEA ratio were 84.8% and 802%, respectively, when the CYFRA 21-1/CEA ratio cut-off value determined by receiver operating characteristic curve analysis was 19.1. Conclusion: MPM should be suspected when the CYFRA 21-1/CEA ratio in pleural effusion is greater than 19.1.
引用
收藏
页码:4343 / 4346
页数:4
相关论文
共 50 条
  • [31] Mesothelin Is More Useful in Pleural Effusion than in Serum in the Diagnosis of Pleural Mesothelioma
    Ferro, Paola
    Canessa, Pier Aldo
    Battolla, Enrico
    Dessanti, Paolo
    Franceschini, Maria Cristiana
    Chiaffi, Luigi
    Morabito, Anna
    Fontana, Vincenzo
    Pezzi, Riccardo
    Fedeli, Franco
    Pistillo, Maria Pia
    Roncella, Silvio
    ANTICANCER RESEARCH, 2013, 33 (06) : 2707 - 2713
  • [32] Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion
    Krishnan, Vishnu G.
    Kunoor, Akhilesh
    Keechilath, Pavithran
    Mehta, Asmita Anilkumar
    LUNG INDIA, 2021, 38 (02) : 139 - 143
  • [33] Naftopidil Is Useful for the Treatment of Malignant Pleural Mesothelioma
    Mikami, Koji
    Nagaya, Hisao
    Gotoh, Akinobu
    Kanno, Takeshi
    Tsuchiya, Ayako
    Nakano, Takashi
    Nishizaki, Tomoyuki
    PHARMACOLOGY, 2014, 94 (3-4) : 163 - 169
  • [34] Accuracy of pleural carcinoembryonic antigen (CEA) assay in malignant pleural effusions
    Basso, S. M. M.
    Tozzoli, R.
    Falcomer, F.
    Del Conte, A.
    Chiara, G. B.
    Lumachi, F.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S82 - S83
  • [35] Usefulness of carcinoembryonic antigen in pleural effusion diagnosis - Reply
    Garcia-Pachon, E
    Padilla-Navas, I
    CHEST, 1998, 113 (05) : 1426 - 1426
  • [36] IS GALECTIN-3 ANTIBODY A USEFUL MARKER IN THE DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA?
    Mlika, Mona
    Ayadi-Kaddour, Aida
    Ksantini, Meriem
    Bouraoui, Saadia
    Mzabi, Sabah
    El Mezni, Faouzi
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2013, 34 (02): : 111 - 125
  • [37] Carcinoembryonic antigen in pleural effusion of patients with lung adenocarcinoma: a predictive marker for EGFR mutation
    Lv, Yan-Ling
    Liu, Hong-Bing
    Yuan, Dong-Mei
    Zhou, Li
    Jin, Shu-Xian
    Song, Yong
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1027 - 1034
  • [38] Is Serum Thioredoxin-1 a Useful Clinical Marker for Malignant Pleural Mesothelioma?
    Maeda, Risa
    Tabata, Chiharu
    Tabata, Rie
    Eguchi, Ryoji
    Fujimori, Yoshihiro
    Nakano, Takashi
    ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (03) : 685 - 689
  • [39] Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion
    Tsuji, S.
    Tsuura, Y.
    Morohoshi, T.
    Shinohara, T.
    Oshita, F.
    Yamada, K.
    Kameda, Y.
    Ohtsu, T.
    Nakamura, Y.
    Miyagi, Y.
    BRITISH JOURNAL OF CANCER, 2010, 103 (04) : 517 - 523
  • [40] Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion
    Yamazoe, Masatoshi
    Ozasa, Hiroaki
    Hak, Young
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : E251 - E253